Related Experiment Video
Updated: Feb 7, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Aleksandra Kezic1,2, Ljiljana Popovic1,3, Katarina Lalic1,3
1Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia.
mTOR inhibitors show antiaging potential but can cause glucose intolerance. Metformin, a diabetes drug, may counteract these side effects, suggesting concurrent use to prevent diabetes in transplant patients.
Area of Science:
- Biochemistry
- Pharmacology
- Metabolic Disease
Background:
- Mechanistic target of rapamycin (mTOR) integrates nutrient signals.
- mTOR inhibitors (rapalogs) have antiaging and immunosuppressive roles.
- Chronic mTOR inhibition can lead to glucose intolerance and insulin resistance.
Purpose of the Study:
- Review metabolic consequences of mTOR inhibitors on glucose metabolism.
- Compare these effects with metformin's metabolic profile.
- Suggest concurrent metformin and rapalog use to mitigate diabetes risk.
Main Methods:
- Literature review of mTOR inhibitors and metformin.
- Analysis of metabolic effects on glucose and insulin sensitivity.
- Comparison of drug-induced metabolic changes.
Main Results:
- Acute mTOR inhibition mimics calorie restriction; chronic inhibition causes insulin resistance.
- Metformin activates AMPK, lowers glucose, and increases fatty acid oxidation.
- Rapalogs can induce hyperglycemia, while metformin improves glucose control.
Conclusions:
- Chronic mTOR inhibition poses a risk for developing type II diabetes.
- Metformin's AMPK activation offers a protective metabolic profile.
- Concurrent metformin and rapalog use may prevent rapalog-induced diabetes, especially in transplant recipients.
Related Concept Videos
Timing and Consequences on Behavior
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Standing Waves
What is Metabolism?
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Modes of Standing Waves - I

